Tutorials and Fundamentals
What is the future of EBM in the US?
What is the future of EBM in the US, both in policy and in reality?
A network for students interested in evidence-based health care
What is the future of EBM in the US, both in policy and in reality?
Your patient has mild hypertension. What should you do?
Treat the hypertension.
Okay, how should you treat the hypertension?
Well, let’s start with HCTZ, that’s well-tolerated.
What will that do?
It’s a diuretic; it’ll help her get rid of the extra volume.
Okay, what will that do?
It’ll lower her blood pressure.
Okay, what will that do?
What do you mean, what will that do?
What will lowering her blood pressure do?
It’ll lower her blood pressure! Seriously—who are you anyway?
Register to become an S4BE Contributor
A beginner’s guide to standard deviation and standard error: what are they, how are they different and how do you calculate them?
When you see a claim that a treatment or intervention has no effect, it is important to examine the evidence as this may be a misleading statement.
This blog provides a detailed overview of the concept of ‘blinding’ in randomised controlled trials (RCTs). It covers what blinding is, common methods of blinding, why blinding is important, and what researchers might do when blinding is not possible. It also explains the concept of allocation concealment.